<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Loperamide - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Loperamide</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">GI</div>
      <h1>Loperamide</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Loperamide 2mg Capsules</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Acute, non-bloody diarrhea (adjunct to oral rehydration)</strong>
            <ul>
              <li>4 mg PO once (2 capsules), then 2 mg PO (1 capsule) after each loose stool</li>
              <li>Max: 8 mg/day (4 capsules) unless directed otherwise by medical authority</li>
              <li>Stop and reassess if symptoms persist &gt;48 hours, or if red flags develop</li>
            </ul>
          </li>
          <li><strong>Chronic diarrhea (provider-directed)</strong>
            <ul>
              <li>Use lowest effective dose; reassess cause and ongoing need</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Symptomatic control of acute, non-specific non-bloody diarrhea (as an adjunct to rehydration)</li>
          <li>Selected chronic diarrhea situations (provider-directed)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Suspected infectious dysentery: blood/mucus in stool and/or high fever</li>
          <li>Suspected or confirmed C. difficile / antibiotic-associated colitis (avoid antimotility agents)</li>
          <li>Acute ulcerative colitis flare or toxic megacolon risk (avoid)</li>
          <li>Significant abdominal distension, ileus, or suspected obstruction (avoid)</li>
          <li><strong>Caution:</strong>
            <ul>
              <li>Hepatic impairment (increased CNS effects)</li>
              <li>Overuse/high doses can cause serious cardiac arrhythmias (do not exceed recommended dose)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Constipation</li>
          <li>Abdominal cramps, nausea</li>
          <li>Dizziness/drowsiness (uncommon)</li>
          <li>Rare but serious (usually overdose/misuse): ileus, toxic megacolon, QT prolongation/arrhythmias</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO capsules with water</li>
          <li>Prioritize rehydration (oral rehydration solution if available); loperamide is symptom control, not definitive treatment</li>
          <li>Avoid combining with other constipating agents unless specifically intended and monitored</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Stool frequency/consistency and abdominal pain</li>
          <li>Hydration status (orthostasis, urine output, mucous membranes)</li>
          <li>Red flags: fever, bloody stool, severe pain, dehydration, worsening distension, persistent symptoms &gt;48 hours</li>
          <li>If constipation develops, stop and reassess</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>In outbreaks (shipboard gastroenteritis): focus on hydration, isolation/hygiene measures, and careful screening for red flags</li>
          <li>Avoid masking severe infectious illness; low threshold to reassess if systemic symptoms, dehydration, or blood/fever present</li>
          <li>Document dose/timing to prevent accidental overuse; ensure maximum daily dose is not exceeded</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (loperamide; dosing/contraindications): <a href="https://pdf.hres.ca/dpd_pm/00075167.PDF" target="_blank">https://pdf.hres.ca/dpd_pm/00075167.PDF</a></li>
          <li>College of Registered Nurses of Saskatchewan (Acute Diarrhea: Adult CDT; includes loperamide dosing guidance): <a href="https://crns.ca/wp-content/uploads/2022/06/Acute-Diarrhea-Adult-CDT-2022.pdf" target="_blank">https://crns.ca/wp-content/uploads/2022/06/Acute-Diarrhea-Adult-CDT-2022.pdf</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
